Literature DB >> 9422817

Scavenging of hydroxyl radicals but not of peroxynitrite by inhibitors and substrates of nitric oxide synthases.

A Rehman1, M Whiteman, B Halliwell.   

Abstract

1. The nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) is widely used to study the role of NO. in physiological and pathological processes, including its role in the generation of the cytotoxic species peroxynitrite (ONOO-) and of reactive oxygen radicals such as hydroxyl (OH.). Often L-NAME is applied to tissues at mM concentrations. At such high concentrations, it might act as a free radical scavenger. A similar possibility might apply to the use of high levels of arginine to study the role of NO. in atherogenesis. 2. We therefore examined the rate of scavenging of OH. by L-NAME and found that L-NAME reacts more quickly with OH. than the established 'OH. scavenger' mannitol and the widely used 'OH. trap' salicylate. However, D-NAME can scavenge OH. at rates equal to L-NAME. Both L- and D-arginine were also good OH. scavengers, comparable in effectiveness to mannitol. 3. Neither L-NAME, D-NAME, L-arginine nor D-arginine was able to inhibit ONOO(-)-dependent nitration of tyrosine, suggesting that they are unlikely to be scavengers of ONOO(-)-derived nitrating species. 4. Neither L-NAME, D-NAME, L-arginine nor D-arginine was able to inhibit the inactivation of alpha 1-antiproteinase by ONOO-, suggesting that they cannot prevent direct oxidations by peroxynitrite. 5. We conclude that L-NAME has sufficient activity as an OH. scavenger to confound certain pharmacological experiments. However, this explanation of its biological effects can be ruled out if control experiments show that D-NAME has no effect and that L-arginine (also a free radical scavenger) antagonizes the action of L-NAME.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422817      PMCID: PMC1565113          DOI: 10.1038/sj.bjp.0701556

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Arginine and nitrate tolerance.

Authors:  R J MacAllister
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  The influence of short-term L-arginine supplementation on rats' muscular and hepatic cells in ischemia-reperfusion syndrome.

Authors:  Przemysław Sosnowski; Hanna Krauss; Pawel Bogdanski; Joanna Suliburska; Anna Jablecka; Artur Cieslewicz; Danuta Pupek-Musialik; Rafał Jastak
Journal:  J Physiol Biochem       Date:  2011-09-27       Impact factor: 4.158

3.  Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate.

Authors:  W H Kaesemeyer; A A Ogonowski; L Jin; R B Caldwell; R W Caldwell
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

4.  Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of alpha1-antiproteinase by mercaptoethylguanidine.

Authors:  M Whiteman; C Szabó; B Halliwell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Neuroprotective Efficacy of Mitochondrial Antioxidant MitoQ in Suppressing Peroxynitrite-Mediated Mitochondrial Dysfunction Inflicted by Lead Toxicity in the Rat Brain.

Authors:  Arpan Kumar Maiti; Nimai Chandra Saha; Sunil S More; Ashish Kumar Panigrahi; Goutam Paul
Journal:  Neurotox Res       Date:  2017-01-03       Impact factor: 3.911

6.  Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis.

Authors:  Spoorthi B Chandraiah; Shashwati Ghosh; Ishita Saha; Sunil S More; Gautham S Annappa; Arpan K Maiti
Journal:  3 Biotech       Date:  2021-03-29       Impact factor: 2.406

7.  Serum hydroxyl radical scavenging capacity as quantified with iron-free hydroxyl radical source.

Authors:  Nobuyuki Endo; Shigeru Oowada; Yoshimi Sueishi; Masashi Shimmei; Keisuke Makino; Hirotada Fujii; Yashige Kotake
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

8.  Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.

Authors:  Hui-fang Zhou; Huimin Yan; Ying Hu; Luke E Springer; Xiaoxia Yang; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Christine T N Pham
Journal:  ACS Nano       Date:  2014-06-24       Impact factor: 15.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.